Northwestern Mutual Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
QCM
Northwestern Mutual Wealth Management's NVCR Position: Q2 2026 in Review
Northwestern Mutual Wealth Management sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 40 shares — an estimated $436 sold.
Northwestern Mutual Wealth Management first reported a position in NVCR in Q1 2016 and held it in 16 quarters. The position peaked at $32K in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Northwestern Mutual Wealth Management reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 40 NovoCure shares in Q2 2026, an estimated $436.
- Northwestern Mutual Wealth Management first reported a position in NovoCure in Q1 2016 and held it in 16 quarters.
- Northwestern Mutual Wealth Management's NovoCure position peaked at $32K in Q2 2021.
- 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.